Posters
SORT BY PROGRAM
All   •   Cefepime-Taniborbactam   •   Ceftibuten/VNRX-7145   •   VNRX-9945

International Liver Congress 2021

June 23 - 26, 2021
Discovery and preclinical profile of VNRX-9945, a potent, broadly active core protein inhibitor for the treatment of chronic hepatitis B virus (HBV) infection
You are using a browser that is not supported. Please consider changing your browser